番茄社区app

Endocrinology >

Type 2 Diabetes

News, opinions and meeting coverage in endocrinology.

FDA APPROVED Generic liraglutide (Victoza) over a photo of a man self-injecting diabetes medication.

First Generic of Once-Daily GLP-1 Injection Approved for Diabetes

Generic liraglutide approved at dosage for type 2 diabetes only

A photo of a Mounjaro injection pen sitting on a box of four.

FDA Says Compounded Tirzepatide Must Exit the Market

Compounders only have 2 to 3 months left to copy injectable

Endo Break over a computer rendering of a man with illustrated body organs.

Endocrinologist Deserts; U.S. Obesity Declines; New Obesity Definition Coming Soon

News and commentary from the endocrinology world

ASHP over a photo of Ernest N. Morial Convention Center in New Orleans, LA.

Newer Diabetes Drugs Still Under-Prescribed in High-Risk Patients

Cost, insurance coverage likely play outsized role

Medical Assistance in Dying; Health Benefits of Chocolate?

Also in TTHealthWatch: depression treatment after positive screening in primary care

A photo of a woman self-injecting in her thigh with a semaglutide pen.

A New Fad: Microdosing Ozempic

Why it's unlikely to help most people

A photo of a woman holding a smartphone which is displaying an incoming call.

Empathetic Phone Calls Help Vulnerable Diabetes Patients Lower HbA1c

Social support may be key to improving glycemic control, experts say

Are GLP-1 Drug Holidays a Risk Worth Taking?

Experts weigh in on weight regain, cardiometabolic fallout, and the future of tailored care

ASH over a photo of San Diego Convention Center

GLP-1 Drugs Tied to Reduced Risk of Dangerous Blood Clots

20% lower risk of VTE observed in large retrospective study of diabetes patients

A computer rendering of atherosclerosis.

Women's CVD Risk Calculations Barely Budge When Sex-Specific Variables Are Included

Existing models improved only slightly after accounting for certain female risk factors

A screenshot of Bernie Sanders speaking during this hearing.

FDA Panned at Senate Hearing for Failure to Address Diabetes, Obesity Epidemics

Agency has failed to hold food manufacturers accountable, said Sen. Bernie Sanders

An ophthalmoscope image of an eye with diabetic retinopathy.

Empagliflozin Linked to Lower Risk of Diabetic Retinopathy Progression

But the drug didn't appear to lower the risk of incident nonproliferative diabetic retinopathy

Untangling GLP-1 Risks: Are Side Effects Overblown?

Experts tackle myths, data bias, and game-changing outcomes of obesity drugs

A photo of a broken bar of dark chocolate.

New Study Teases Out Chocolate and Diabetes Connection

Eating more dark chocolate was associated with a lower risk of type 2 diabetes

A photo of a tirzepatide (Zepbound) injection pen over an out of focus photo of a barbell wrapped in a measuring tape and a s

Tirzepatide Tops Semaglutide for Weight Loss in Head-to-Head Trial, Eli Lilly Says

Dual GLP-1/GIP drug yielded an average 47% greater relative weight loss compared to semaglutide

GLP-1s: The Medications Redefining Diabetes and Obesity Treatment

Experts tackle access, equity, and the blockbuster drugs reshaping healthcare

Endo Break over a computer rendering of a man with illustrated body organs.

ADA Advises Against Compounded GLP-1s; Growth Hormone Therapy Guide; T1D Outcomes Up

News and commentary from the endocrinology world

A photo of a wad of rolled up $100 bills in a prescription medication bottle.

Drug Prices Negotiated by Medicare Still Higher Than Other Countries'

All drugs except one remained more expensive in the U.S.

The advertisement for this Instagram Live event.

IG Live December 2: The Weight of Wegovy

How GLP-1 drugs are reshaping medicine

Endo Break over a computer rendering of a man with illustrated body organs.

Thyroid Drug & Bone Loss; GLP-1s' Renal Benefit; Menopause Musculoskeletal Syndrome

News and commentary from the endocrinology world

Pouring whisky away down the sink.

Many Drinkers Cut Back After Starting Obesity Meds, Study Finds

In WeightWatchers study, 45% decreased their alcohol use after initiating a weight-loss drug

A photo of a woman taking a reading with her continuous glucose monitor.

CGM Uptake Very Low for Vulnerable Diabetes Populations

But how to achieve equitable use remains "complicated," says expert

A photo of an injection pen.

GLP-1 Use Prior to Surgery: Analyzing the Updated Guidance

Balancing aspiration risk with the consequences of medication discontinuation

A photo of a glucose meter lying on a box of metformin tablets.

Metformin Use Linked to Fewer Asthma Attacks

Addition of GLP-1 drugs led to an even greater reduction

Endo Break over a computer rendering of a man with illustrated body organs.

75% of Adults Overweight or Obese; Global Diabetes Tx Lacking; Hidden Bone Data?

News and commentary from the endocrinology world

AHA over a photo of McCormick Place Convention Center in Chicago, IL.

Over 50% of U.S. Adults Qualify for Ozempic, Wegovy

Most are eligible for weight management indication

Extended Dosing Intervals Possible With Aflibercept in Diabetic Macular Edema

In the third year, 88% of patients could go 12 weeks or longer with 8-mg dose

AHA over a photo of McCormick Place Convention Center in Chicago, IL.

Tirzepatide Officially Puts GLP-1 Meds on the Map for Heart Failure Benefit

SUMMIT trial able to show clinical benefit beyond quality-of-life improvement

Multiple Chronic Conditions and Death; Diabetes Treatment for Gout

Also in TTHealthWatch: frailty as a predictor of dementia

A photo of a man holding a semaglutide injection pen.

GLP-1 Drugs Could Help People With Alcohol Use Disorder

Real-world data suggested semaglutide, liraglutide reduced AUD-related hospitalizations

Endo Break over a computer rendering of a man with illustrated body organs.

16% of Adults Have Diabetes; Compounded Semaglutide Deaths; Testosterone Tx Surge

News and commentary from the endocrinology world

Who Needs a Defibrillator After MI? FDA Recs on Inferior Vena Cava Filters

Also in TTHealthWatch: early sugar exposure, hypertension, and diabetes

A close up photo of a needle of a semaglutide injection pen.

FDA Adds New Warning to GLP-1 Drugs

Labels now caution about pulmonary aspiration risk

A photo of diabetic retinopathy.

Slow Start for AI-Assisted Screening for Diabetic Retinopathy Despite Promise

Ophthalmologists hope expanded use will lead to more evaluations in primary clinics

Morning Break over illustration of a syringe, Covid virus, and DNA helix over a photo of green vegetation.

Nurse's Death Tied to GLP-1 Drug; Research Monkey Jailbreak; Congressman Has Cancer

Health news and commentary gathered by 番茄社区app staff

ObesityWeek over a photo of Henry B. Gonz谩lez Convention Center in San Antonio, TX.

Zepbound's Weight Loss, Cardiometabolic Benefits Hold Up at 3 Years

Nearly all participants in SURMOUNT-1 avoided diabetes with the GLP-1/GIP receptor agonist

ObesityWeek over a photo of Henry B. Gonz谩lez Convention Center in San Antonio, TX.

Early-Life Sugar Restriction Reduced Diabetes, Hypertension Risk

Diagnoses were also delayed the longer sugar was restricted

ACG over a photo of Pennsylvania Convention Center in Philadelphia, PA.

Do GLP-1 Agonists Really Need to Be Stopped Before Endoscopy?

Meta-analysis suggests 24-hour clear liquid diet works to avoid aspiration, even with GLP-1s

Endo Break over a computer rendering of a man with illustrated body organs.

CGM OK'd During Medical Imaging; All Semaglutide Doses Back; Bariatric Surgery Down

News and commentary from the endocrinology world

A photo of a patient's perspective of an anesthesiologist lowering a mask.

ASA Advises No Longer Holding GLP-1 Agents Prior to Surgery for Most Patients

New guidance replaces earlier rec of a 1-week and 1-day hold of injectable and oral GLP-1 agents

1

鈥�